Abstract
Summary
Fecal microbiota transplantation refers to the practice of transplanting stool from a healthy donor into the gastrointestinal tract of the patient. This procedure restores the balance of bacteria in the digestive tract by replenishing the population of ‘good’ bacteria that is either suppressed by the overpopulation of ‘bad’ bacteria or has been killed. Prepared fecal microbiota transplantation is a thoroughly screened process. It is carried out in the lower gastrointestinal tract through colonoscopy or enema and in the upper gastrointestinal tract through the nasoduodenal or nasogastric tube. Currently, fecal microbiota transplantation is being studied for the treatment of Clostridium difficile infection but can be used for the treatment of gut dysbiosis after heavy treatment such as chemotherapy. Patietns with recurrent clostridium infections treated with fecal microbiota transplantation have shown high rates of success. A study has found that 90% recurrent C. difficile cases treated with fecal microbiota transplantation achieve clinical resolution. Thus, this has elevated fecal microbiota transplantation as an emerging treatment for a wide range of disorders, including fibromyalgia, Parkinson’s disease, myoclonus dystopia, chronic fatigue syndrome, multiple sclerosis, insulin resistance, obesity, metabolic syndrome, and autism.
LPI (LP Information)' newest research report, the “Fecal Microbiota Transplantation Industry Forecast” looks at past sales and reviews total world Fecal Microbiota Transplantation sales in 2022, providing a comprehensive analysis by region and market sector of projected Fecal Microbiota Transplantation sales for 2023 through 2029. With Fecal Microbiota Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fecal Microbiota Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Fecal Microbiota Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fecal Microbiota Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fecal Microbiota Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fecal Microbiota Transplantation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fecal Microbiota Transplantation.
The global Fecal Microbiota Transplantation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Fecal Microbiota Transplantation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Fecal Microbiota Transplantation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Fecal Microbiota Transplantation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Fecal Microbiota Transplantation players cover Rebiotix, Finch Therapeutics, Seres Therapeutics and Crestovo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Fecal Microbiota Transplantation market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Phase-I
Phase-2
Phase-3
Phase-4
Segmentation by application
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
LPI (LP Information)' newest research report, the “Fecal Microbiota Transplantation Industry Forecast” looks at past sales and reviews total world Fecal Microbiota Transplantation sales in 2022, providing a comprehensive analysis by region and market sector of projected Fecal Microbiota Transplantation sales for 2023 through 2029. With Fecal Microbiota Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fecal Microbiota Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Fecal Microbiota Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fecal Microbiota Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fecal Microbiota Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fecal Microbiota Transplantation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fecal Microbiota Transplantation.
The global Fecal Microbiota Transplantation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Fecal Microbiota Transplantation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Fecal Microbiota Transplantation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Fecal Microbiota Transplantation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Fecal Microbiota Transplantation players cover Rebiotix, Finch Therapeutics, Seres Therapeutics and Crestovo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Fecal Microbiota Transplantation market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Phase-I
Phase-2
Phase-3
Phase-4
Segmentation by application
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fecal Microbiota Transplantation Market Size 2018-2029
2.1.2 Fecal Microbiota Transplantation Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Fecal Microbiota Transplantation Segment by Type
2.2.1 Phase-I
2.2.2 Phase-2
2.2.3 Phase-3
2.2.4 Phase-4
2.3 Fecal Microbiota Transplantation Market Size by Type
2.3.1 Fecal Microbiota Transplantation Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Fecal Microbiota Transplantation Market Size Market Share by Type (2018-2023)
2.4 Fecal Microbiota Transplantation Segment by Application
2.4.1 Clostridium Difficile Infections
2.4.2 Parkinson Disease
2.4.3 Obesity
2.4.4 Diabetes Mellitus
2.4.5 Autism
2.4.6 Others
2.5 Fecal Microbiota Transplantation Market Size by Application
2.5.1 Fecal Microbiota Transplantation Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Fecal Microbiota Transplantation Market Size Market Share by Application (2018-2023)
3 Fecal Microbiota Transplantation Market Size by Player
3.1 Fecal Microbiota Transplantation Market Size Market Share by Players
3.1.1 Global Fecal Microbiota Transplantation Revenue by Players (2018-2023)
3.1.2 Global Fecal Microbiota Transplantation Revenue Market Share by Players (2018-2023)
3.2 Global Fecal Microbiota Transplantation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Fecal Microbiota Transplantation by Regions
4.1 Fecal Microbiota Transplantation Market Size by Regions (2018-2023)
4.2 Americas Fecal Microbiota Transplantation Market Size Growth (2018-2023)
4.3 APAC Fecal Microbiota Transplantation Market Size Growth (2018-2023)
4.4 Europe Fecal Microbiota Transplantation Market Size Growth (2018-2023)
4.5 Middle East & Africa Fecal Microbiota Transplantation Market Size Growth (2018-2023)
5 Americas
5.1 Americas Fecal Microbiota Transplantation Market Size by Country (2018-2023)
5.2 Americas Fecal Microbiota Transplantation Market Size by Type (2018-2023)
5.3 Americas Fecal Microbiota Transplantation Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fecal Microbiota Transplantation Market Size by Region (2018-2023)
6.2 APAC Fecal Microbiota Transplantation Market Size by Type (2018-2023)
6.3 APAC Fecal Microbiota Transplantation Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Fecal Microbiota Transplantation by Country (2018-2023)
7.2 Europe Fecal Microbiota Transplantation Market Size by Type (2018-2023)
7.3 Europe Fecal Microbiota Transplantation Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fecal Microbiota Transplantation by Region (2018-2023)
8.2 Middle East & Africa Fecal Microbiota Transplantation Market Size by Type (2018-2023)
8.3 Middle East & Africa Fecal Microbiota Transplantation Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Fecal Microbiota Transplantation Market Forecast
10.1 Global Fecal Microbiota Transplantation Forecast by Regions (2024-2029)
10.1.1 Global Fecal Microbiota Transplantation Forecast by Regions (2024-2029)
10.1.2 Americas Fecal Microbiota Transplantation Forecast
10.1.3 APAC Fecal Microbiota Transplantation Forecast
10.1.4 Europe Fecal Microbiota Transplantation Forecast
10.1.5 Middle East & Africa Fecal Microbiota Transplantation Forecast
10.2 Americas Fecal Microbiota Transplantation Forecast by Country (2024-2029)
10.2.1 United States Fecal Microbiota Transplantation Market Forecast
10.2.2 Canada Fecal Microbiota Transplantation Market Forecast
10.2.3 Mexico Fecal Microbiota Transplantation Market Forecast
10.2.4 Brazil Fecal Microbiota Transplantation Market Forecast
10.3 APAC Fecal Microbiota Transplantation Forecast by Region (2024-2029)
10.3.1 China Fecal Microbiota Transplantation Market Forecast
10.3.2 Japan Fecal Microbiota Transplantation Market Forecast
10.3.3 Korea Fecal Microbiota Transplantation Market Forecast
10.3.4 Southeast Asia Fecal Microbiota Transplantation Market Forecast
10.3.5 India Fecal Microbiota Transplantation Market Forecast
10.3.6 Australia Fecal Microbiota Transplantation Market Forecast
10.4 Europe Fecal Microbiota Transplantation Forecast by Country (2024-2029)
10.4.1 Germany Fecal Microbiota Transplantation Market Forecast
10.4.2 France Fecal Microbiota Transplantation Market Forecast
10.4.3 UK Fecal Microbiota Transplantation Market Forecast
10.4.4 Italy Fecal Microbiota Transplantation Market Forecast
10.4.5 Russia Fecal Microbiota Transplantation Market Forecast
10.5 Middle East & Africa Fecal Microbiota Transplantation Forecast by Region (2024-2029)
10.5.1 Egypt Fecal Microbiota Transplantation Market Forecast
10.5.2 South Africa Fecal Microbiota Transplantation Market Forecast
10.5.3 Israel Fecal Microbiota Transplantation Market Forecast
10.5.4 Turkey Fecal Microbiota Transplantation Market Forecast
10.5.5 GCC Countries Fecal Microbiota Transplantation Market Forecast
10.6 Global Fecal Microbiota Transplantation Forecast by Type (2024-2029)
10.7 Global Fecal Microbiota Transplantation Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Rebiotix
11.1.1 Rebiotix Company Information
11.1.2 Rebiotix Fecal Microbiota Transplantation Product Offered
11.1.3 Rebiotix Fecal Microbiota Transplantation Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Rebiotix Main Business Overview
11.1.5 Rebiotix Latest Developments
11.2 Finch Therapeutics
11.2.1 Finch Therapeutics Company Information
11.2.2 Finch Therapeutics Fecal Microbiota Transplantation Product Offered
11.2.3 Finch Therapeutics Fecal Microbiota Transplantation Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Finch Therapeutics Main Business Overview
11.2.5 Finch Therapeutics Latest Developments
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Information
11.3.2 Seres Therapeutics Fecal Microbiota Transplantation Product Offered
11.3.3 Seres Therapeutics Fecal Microbiota Transplantation Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Seres Therapeutics Main Business Overview
11.3.5 Seres Therapeutics Latest Developments
11.4 Crestovo
11.4.1 Crestovo Company Information
11.4.2 Crestovo Fecal Microbiota Transplantation Product Offered
11.4.3 Crestovo Fecal Microbiota Transplantation Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Crestovo Main Business Overview
11.4.5 Crestovo Latest Developments
12 Research Findings and Conclusion